suramin analogs (University of Bonn)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namesuramin analogs (University of Bonn)
Drug Alias NameP2X3 receptor antagonists (University of Bonn)NF-062NF-503MK-3NF-110 +[7] 
ClassificationSmall molecules
Mechanisms of ActionMatrix metalloproteinase-2 inhibitorsAngiogenesis inhibitorsP2X purinoceptor 3 antagonists
TargetsP2X purinoceptor 3Matrix metalloproteinase-2
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bonn
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Bonn
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A